| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8fbdef21d37b249a704282836c93cd1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2006-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73e594bea2db6a28f6a934b98cb2fa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e35a866393ea3a04544438d28c582f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ebb01c957f37c92517db16498b6685a |
| publicationDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006292165-A1 |
| titleOfInvention |
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation |
| abstract |
Compositions and methods for eliciting an in vivo cytotoxic lymphocyte (CTL) response against a modified soluble protein antigen are disclosed. The modified soluble protein antigen comprises an added peptidic sequence which facilitates entry of the modified antigen into antigen presenting cells (APC). |
| priorityDate |
1998-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |